D. Michael Jones

424 citations

16 papers · 322 indexed · h-index 11

Impact in

Genetics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology

Papers in

Genetics 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 2
Endocrinology, Diabetes and Metabolism 4
- Diabetes Treatment and Management 2
- Hormonal Regulation and Hypertension 2

Co-authors: Michael Szelke Butrus Atrash Doreen M. Ashworth Andrew Baxter James J. Morton B Leckie Anthony F. Lever Allan Hallett
Journals: Journal of Hypertension (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Addictive Behaviors (1 paper)Journal of Cardiovascular Pharmacology (1 paper)British Journal of Clinical Pharmacology (1 paper)
Partner nations: United Kingdom United States Australia

In The Last Decade

D. Michael Jones

16 papers receiving 314 citations

Peers

Countries citing papers authored by D. Michael Jones

Since Specialization

Citations

This map shows the geographic impact of D. Michael Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Michael Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Michael Jones more than expected).

Fields of papers citing papers by D. Michael Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Michael Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Michael Jones. The network helps show where D. Michael Jones may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Michael Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Michael Jones Line = papers co-authored together D. Michael Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis ·Jeremy M. Shefner, Jesse M. Cedarbaum, Merit Cudkowicz, Nicholas J. Maragakis, Jacqueline Lee, D. Michael Jones, Mary Lou Watson, Katy Mahoney, Rongfeng Fu, Khalil G. Saikali, John Mao, Alan J. Russell, Richard L. Hansen, 准一松田, Andrew A. Wolff, (unknown)	2012	32
2	Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses British Journal of Clinical Pharmacology ·Paul Rolan, Jacqueline A. Gibbons, Joseph Callaway, William M. Parkins, D. Michael Jones, Matthew Gross, JÜRGEN HENGELBROCK, Laura Sanftner, Kirk W. Johnson	2008	58
3	Synthetic inhibitors of human tissue kallikrein Immunopharmacology ·Declan Evans, D. Michael Jones, David N Leff, Doreen M. Ashworth, Fred De Clerck, Fons Verheyen, Michael Szelke	1996	16
4	Selective inhibitors of plasma kallikrein Immunopharmacology ·Declan Evans, D. Michael Jones, David N Leff, Javier Sueiras-Diaz, J.R. Horton, Doreen M. Ashworth, P. J. Armstrong, Michael Szelke	1996	7
5	4-cyanothiazolidides as very potent, stable inhibitors of dipeptidyl peptidase IV Bioorganic & Medicinal Chemistry Letters ·Doreen M. Ashworth, Butrus Atrash, Mehmet Burhan Oşaz, Andrew Baxter, Quan Junjia, D. Michael Jones, Michael Szelke	1996	13
6	2-cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV Bioorganic & Medicinal Chemistry Letters ·Doreen M. Ashworth, Butrus Atrash, Mehmet Burhan Oşaz, Andrew Baxter, Quan Junjia, D. Michael Jones, Michael Szelke	1996	59
7	Thrombin Inhibitors Based on Ketone Derivatives of Arginine and Lysine Journal of enzyme inhibition ·D. Michael Jones, Butrus Atrash, Hamish Ryder, Ann‐Catrine Teger‐Nilsson, Hagit Doitch, Michael Szelke	1995	10
8	Design and synthesis of thrombin inhibitors Letters in Peptide Science ·D. Michael Jones, Butrus Atrash, Ann‐Catrine Teger‐Nilsson, Hagit Doitch, Johanna Deinum, Michael Szelke	1995	10
9	A short stereocontrolled synthesis of hydroxyethylene dipeptide isosteres The Journal of Organic Chemistry ·D. Michael Jones, Katarzyna Kwiecień, Michael Szelke	1993	16
10	Inhibitors of rat renin and their use in experimental hypertension Journal of Hypertension ·Elisabeth Beattie, James J. Morton, B Leckie, Javier Sueiras-Diaz, D. Michael Jones, Michael Szelke	1989	1
11	Clinical and Biochemical Effects of the Renin Inhibitor H142 in Humans Journal of Cardiovascular Pharmacology ·David J. Webb, Per Manhem, Stephen G. Ball, Gordon C. Inglis, B Leckie, Anthony F. Lever, James J. Morton, J. I. S. Robertson, Gordon Murray, Joël Ménard, Allan Hallett, D. Michael Jones, Michael Szelke	1987	5
12	A Study of the Renin Inhibitor H142 in Man Journal of Hypertension ·David J. Webb, Per Manhem, Stephen G. Ball, Gordon C. Inglis, B Leckie, Anthony F. Lever, James J. Morton, J. I. S. Robertson, Gordon Murray, (unknown), Allan Hallett, D. Michael Jones, Michael Szelke	1985	42
13	A Transition-state Analogue Inhibitor of Human Renin (H.261): Test in vitro and a Comparison with Captopril in the Anaesthetized Baboon Journal of Hypertension ·Michael Szelke, M. Tree, B Leckie, D. Michael Jones, Butrus Atrash, A al-Iryani, Brian T. Donovan, Allan Hallett, JamalKansao, Anthony F. Lever, James J. Morton, Javier Sueiras-Diaz	1985	23
14	New Inhibitors of Human Renin Tested in vitro and in vivo in the Anaesthetized Baboon Journal of Hypertension ·M. Tree, Butrus Atrash, Brian T. Donovan, John F. Gamble, Allan Hallett, JamalKansao, D. Michael Jones, B Leckie, Anthony F. Lever, James J. Morton, Michael Szelke	1983	20
15	Reducing junk food palatability and consumption by aversive conditioning Addictive Behaviors ·Edward E. Abramson, D. Michael Jones	1981	3
16	Mesoporphyrinogen-VI: a substrate for coproporphyrinogen oxidase Journal of the Chemical Society Chemical Communications ·Anthony H. Jackson, D. Michael Jones, S.G. Smith, George H. Elder	1976	7

About D. Michael Jones

D. Michael Jones is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism, Pharmacology, Cardiology and Cardiovascular Medicine and Sensory Systems, having authored 16 papers that have together received 322 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (5 papers), Peptidase Inhibition and Analysis (3 papers), Chemical Synthesis and Analysis (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Diabetes Treatment and Management (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Hormonal Regulation and Hypertension (2 papers) and Beetle Biology and Toxicology Studies (1 paper). The work is most often cited by research in Genetics (57 citations), Cellular and Molecular Neuroscience (82 citations), Endocrinology, Diabetes and Metabolism (74 citations), Oncology (93 citations) and Cardiology and Cardiovascular Medicine (70 citations). D. Michael Jones has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Michael Szelke, Butrus Atrash, Doreen M. Ashworth, Andrew Baxter, James J. Morton, B Leckie, Anthony F. Lever, Allan Hallett, Matthew Gross and Paul Rolan. Their work appears in journals such as Journal of Hypertension, Bioorganic & Medicinal Chemistry Letters, Addictive Behaviors, Journal of Cardiovascular Pharmacology and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact